_id

690da9b7ccc777a4e85d086d

Ticker

ADIL

Name

Adial Pharmaceuticals Inc

Exchange

NASDAQ

Address

4870 Sadler Road, Glen Allen, VA, United States, 23060

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.adial.com

Description

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.

Last Close

0.2971

Volume

528355

Current Price

0.2956

Change

-0.5048805116122522

Last Updated

2025-11-28T11:51:26.355Z

Image

data:image/webp;base64,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

Ipo Date

2018-07-30T00:00:00.000Z

Market Cap

7436152

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.998

Sentiment Sources

1

Rating

4.3333

Target Price

2.1667

Strong Buy

2

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

141

Gross Profit

-141

Operating Expenses

1763937

Operating Income

-1764078

Interest Expense

-

Pretax Income

-1793651

Net Income

-1793651

Eps

-0.08089964376934172

Dividends Per Share

-

Shares Outstanding

23987587

Income Tax Expense

-

EBITDA

-1793510

Operating Margin

-

Total Other Income Expense Net

-29573

Cash

4606289

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

5013832

Property Plant Equipment

-

Total Assets

5659847

Payables

556284

Short Term Debt

-

Long Term Debt

-

Total Liabilities

1154756

Equity

4505091

Depreciation

141

Change In Working Capital

-264117

Cash From Operations

-1833373

Capital Expenditures

3

Cash From Investing

-

Cash From Financing

524682

Net Change In Cash

-1308691

PE

-

PB

1.454762831738582

ROE

-39.813868354712476

ROA

-31.69080365599989

FCF

-1833376

Fcf Percent

-

Piotroski FScore

0

Health Score

42

Deep Value Investing Score

5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

3.5

Quality Investing Score

3

Value Investing Score

6.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

141

Quarters > 0 > income Statement > gross Profit

-141

Quarters > 0 > income Statement > operating Expenses

1763937

Quarters > 0 > income Statement > operating Income

-1764078

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1793651

Quarters > 0 > income Statement > net Income

-1793651

Quarters > 0 > income Statement > eps

-0.08089964376934172

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

22171309

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1793510

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-29573

Quarters > 0 > balance Sheet > cash

4606289

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

5013832

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

5659847

Quarters > 0 > balance Sheet > payables

556284

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1154756

Quarters > 0 > balance Sheet > equity

4505091

Quarters > 0 > cash Flow > net Income

-1793651

Quarters > 0 > cash Flow > depreciation

141

Quarters > 0 > cash Flow > change In Working Capital

-264117

Quarters > 0 > cash Flow > cash From Operations

-1833373

Quarters > 0 > cash Flow > capital Expenditures

3

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

524682

Quarters > 0 > cash Flow > net Change In Cash

-1308691

Quarters > 0 > ratios > PE

-0.08089964376934172

Quarters > 0 > ratios > PB

1.454762831738582

Quarters > 0 > ratios > ROE

-39.813868354712476

Quarters > 0 > ratios > ROA

-31.69080365599989

Quarters > 0 > ratios > FCF

-1833376

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

141

Quarters > 1 > income Statement > gross Profit

-141

Quarters > 1 > income Statement > operating Expenses

1882712

Quarters > 1 > income Statement > operating Income

-1882712

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-1958556

Quarters > 1 > income Statement > net Income

-1958556

Quarters > 1 > income Statement > eps

-0.18437424689721654

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

10622720

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1882571

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-75844

Quarters > 1 > balance Sheet > cash

5914980

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

6078627

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

6801703

Quarters > 1 > balance Sheet > payables

671118

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1211027

Quarters > 1 > balance Sheet > equity

5590676

Quarters > 1 > cash Flow > net Income

-1958556

Quarters > 1 > cash Flow > depreciation

141

Quarters > 1 > cash Flow > change In Working Capital

-13685

Quarters > 1 > cash Flow > cash From Operations

-1749271

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

5298471

Quarters > 1 > cash Flow > net Change In Cash

3549200

Quarters > 1 > ratios > PE

-0.18437424689721654

Quarters > 1 > ratios > PB

0.5616630318050982

Quarters > 1 > ratios > ROE

-35.03254347059283

Quarters > 1 > ratios > ROA

-28.79508264327331

Quarters > 1 > ratios > FCF

-1749271

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

141

Quarters > 2 > income Statement > gross Profit

-141

Quarters > 2 > income Statement > operating Expenses

2267293

Quarters > 2 > income Statement > operating Income

-2267293

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-2228801

Quarters > 2 > income Statement > net Income

-2228801

Quarters > 2 > income Statement > eps

-0.11990054413562441

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

18588748

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-2267152

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

38492

Quarters > 2 > balance Sheet > cash

2365780

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

2629175

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

3451122

Quarters > 2 > balance Sheet > payables

532430

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1324460

Quarters > 2 > balance Sheet > equity

2126662

Quarters > 2 > cash Flow > net Income

-2228801

Quarters > 2 > cash Flow > depreciation

141

Quarters > 2 > cash Flow > change In Working Capital

393446

Quarters > 2 > cash Flow > cash From Operations

-1585393

Quarters > 2 > cash Flow > capital Expenditures

3

Quarters > 2 > cash Flow > cash From Investing

150000

Quarters > 2 > cash Flow > cash From Financing

50648

Quarters > 2 > cash Flow > net Change In Cash

-1384745

Quarters > 2 > ratios > PE

-0.11990054413562441

Quarters > 2 > ratios > PB

2.5837833698067674

Quarters > 2 > ratios > ROE

-104.80278483369713

Quarters > 2 > ratios > ROA

-64.58192437126245

Quarters > 2 > ratios > FCF

-1585396

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

564

Quarters > 3 > income Statement > cost Of Revenue

141

Quarters > 3 > income Statement > gross Profit

-141

Quarters > 3 > income Statement > operating Expenses

1940590

Quarters > 3 > income Statement > operating Income

-1940731

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-2070790

Quarters > 3 > income Statement > net Income

-2070790

Quarters > 3 > income Statement > eps

-0.1114001868226951

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

18588748

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-2070649

Quarters > 3 > income Statement > operating Margin

-344101.24113475176

Quarters > 3 > income Statement > total Other Income Expense Net

-130059

Quarters > 3 > balance Sheet > cash

3750525

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

4058764

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

5043942

Quarters > 3 > balance Sheet > payables

250130

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

975858

Quarters > 3 > balance Sheet > equity

4068084

Quarters > 3 > cash Flow > net Income

-2070790

Quarters > 3 > cash Flow > depreciation

141

Quarters > 3 > cash Flow > change In Working Capital

252810

Quarters > 3 > cash Flow > cash From Operations

-1453821

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

0

Quarters > 3 > cash Flow > net Change In Cash

-1453821

Quarters > 3 > ratios > PE

-0.1114001868226951

Quarters > 3 > ratios > PB

1.3507179076931546

Quarters > 3 > ratios > ROE

-50.90332451345646

Quarters > 3 > ratios > ROA

-41.054992305621276

Quarters > 3 > ratios > FCF

-1453821

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-2577.696808510638

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.08089964376934172

Valuation > metrics > PB

1.454762831738582

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-39.813868354712476

Profitability > metrics > ROA

-35.77405465520185

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.256322458303284

Risk > metrics > Interest Coverage

-12511.191489361701

Risk > final Score

-49985

Risk > verdict

High

Liquidity > metrics > Current Ratio

9.013079649962968

Liquidity > metrics > Quick Ratio

9.013079649962968

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-39

Prev Risks > 1

-188

Prev Risks > 2

-54996

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:11:56.198Z